NEW YORK (GenomeWeb) – SGI-DNA announced on Thursday the launch of the early access program for the company's BioXp 3200 system. 

The workstation can simultaneously build 32 unique double-stranded DNA fragments, and enables researchers to produce synthetic DNA fragments "virtually hands-free," according to the company. Daniel Gibson, vice president of DNA technology at SGI-DNA's parent firm, Synthetic Genomics, said in a statement that the company plans to build out the platform's capabilities by continuing to develop downstream applications for synthetic biology. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.